Home › Testicular Cancer
Testicular Cancer clinical trials recruiting in the U.S.
18 studies for Testicular Cancer are recruiting participants at sites across the United States.
Testicular cancer mainly affects young men between the ages of 20 and 39. Symptoms include pain, swelling, or lumps in your testicles or groin area.
Cities with the most studies
- New York City, NY5 studies
- Nashville, TN4 studies
- Durham, NC4 studies
- Dallas, TX3 studies
- Birmingham, AL3 studies
- Indianapolis, IN3 studies
- Baldwin Park, CA3 studies
- Edison, NJ3 studies
- Atlanta, GA3 studies
- Omaha, NE3 studies
By state
- Alabama3 studies
- Arizona4 studies
- California8 studies
- Colorado4 studies
- Florida4 studies
- Georgia3 studies
- Illinois4 studies
- Indiana4 studies
- Massachusetts3 studies
- Minnesota3 studies
- Nebraska3 studies
- New Jersey4 studies
- New York6 studies
- North Carolina6 studies
- Ohio4 studies
- Pennsylvania3 studies
- Tennessee4 studies
- Texas3 studies
- Wisconsin3 studies
Recently updated studies
DESTINY-PANTUMOUR04
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Sep 22, 2026 · NCT06814496A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06515613Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RecruitingPhase 1
Ages 15 and older · All sexes · Updated Aug 25, 2026 · NCT06276491MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial
RecruitingObservational study
Ages 18 and older · Men · Updated Aug 20, 2026 · NCT06060873Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
RecruitingObservational study
Ages 18 to 99 · Men · Updated Jul 27, 2026 · NCT05611307A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jul 24, 2026 · NCT06866964Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
Recruiting
Ages 18 and older · Men · Updated Jul 10, 2026 · NCT06828185Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Recruiting
Ages 21 to 45 · All sexes · Updated Jul 6, 2026 · NCT07406087Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT07407582Brodalumab in the Treatment of Immune-Related Adverse Events
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT06673329Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
RecruitingPhase 1
Ages 18 and older · Men · Updated Apr 17, 2026 · NCT07218913Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
RecruitingPhase 3
Ages 18 to 80 · Men · Updated Feb 13, 2026 · NCT06593665Germ Cell Tumor and Testicular Tumor DNA Registry
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT02099734Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Recruiting
Ages 18 to 39 · All sexes · Updated Jan 28, 2026 · NCT06371768SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
Recruiting
Ages 18 to 39 · Men · Updated May 1, 2025 · NCT05836688From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.